# Ditch Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ditch-labs

- Industry: Medical Devices & Equipment
- Headquarters: Montreal, Canada
- Website: www.ditchlabs.com
- Total disclosed funding: $3.5M
- Latest round: Seed (Mar 1, 2023)
- Investors on record: 9

## About

Based in Montreal, Canada, and founded in 2020 by its CEO, Laurent Laferrière, and CTO, Olivier Bourbonnais, Ditch Labs, operates as a provider of artificial intelligence-based medical vaporizers used for monitoring nicotine quantity. In March 2023, Ditch Labs raised CAD 3.25 million in seed funding co-led by returning investors Amplify Capital and Boréal Ventures, with participation from other returning investors Anges Québec and Symphony Health Network. New investors Investissement Québec, Meditrial, The Kale Fund, and individual investors also participated in the round.

The company offers a medical device, DitchPen™, a medical vaporizer used for providing smoking cessation solutions through personalized experiences for nicotine monitoring. The company also provides a mobile application platform that connects with the device and acts as a behavioral assistant, helping users to overcome nicotine addiction.

## Funding rounds

- Seed, Mar 1, 2023, $2.4M — Investment Quebec, Amplify Capital, Anges Québec, Boreal Ventures, The Kale Fund, Meditrial Europe Ltd., Symphony Care Network, LLC.
- Seed, Apr 16, 2021, $1.1M — Desjardins Capital, Amplify Capital, Anges Québec, Boreal Ventures, Formentera Capital

## Investors

- Desjardins Capital (https://capitalatlas.ai/funds/desjardins-capital) — Seed
- Amplify Capital (https://capitalatlas.ai/funds/amplify-capital) — Seed
- Anges Québec — Seed
- Boreal Ventures (https://capitalatlas.ai/funds/boreal-ventures) — Seed
- Formentera Capital (https://capitalatlas.ai/funds/formentera-capital) — Seed
- Investment Quebec (https://capitalatlas.ai/funds/investment-quebec) — Seed
- The Kale Fund — Seed
- Meditrial Europe Ltd. — Seed
- Symphony Care Network, LLC. — Seed